Kobe2602 is primarily utilized in the field of biomedical research, particularly in the study of cellular signaling pathways. It serves as a potent and selective inhibitor of specific enzymes involved in these pathways, making it a valuable tool for understanding the mechanisms of various diseases, including cancer. Researchers employ Kobe2602 to investigate the role of targeted proteins in cell proliferation, apoptosis, and other critical cellular processes. Its application extends to drug discovery, where it helps in identifying potential therapeutic targets and evaluating the efficacy of novel compounds. Additionally, Kobe2602 is used in experimental models to explore the effects of pathway inhibition on tumor growth and metastasis, contributing to the development of more effective cancer treatments.